Founders

Ashok K Singh, PhD
CEO
Dr. Singh has been in academic medicine for more than 25 years. His research has focused on immune complex diseases, diabetes, diabetic kidney disease, angiogenesis, chronic kidney diseases, stem cells and tissue regeneration. He has published more than 90 papers in peer-reviewed medical and scientific journals including the key papers which led to the VivaStem Technology.

Christopher Serpico, DVM
President
Dr. Serpico has been a successful practicing veterinarian in Chicago since 2002. He is an integrative veterinary doctor applying acupuncture, Chinese herbs, and other alternative therapies in addition to modern veterinary methods. He is involved in ongoing clinical research on the uses of VivaStem Technology in companion animals.

Krishnamurthy P Gudehithlu, PhD
VP, Research
Dr. Gudehithlu is a biochemist and has spent more than 20 years in medical research. His area of expertise is stem cells, and evaluation of urinary exosomal biomarkers in diabetic kidney disease. He has several papers published in peer-reviewed medical and scientific journals including the key papers which led to the VivaStem Technology.

Nishit Pancholi, MD
VP, Development
Dr. Pancholi has extensive basic and clinical research experience. Through his research he has been able to show the utility of the omentum stem cells (belly fat) in organ repair and regeneration. He has published several papers in stem cells, liver regeneration, kidney repair and regeneration including the key papers which led to the VivaStem Technology.

J. Patel, MD
VP, Finance
Dr. Patel has significant experience in the field of stem cells and regenerative medicine. She has published several papers on novel sources of adult stem cells, tissue repair and regeneration, and multiple sclerosis. Her published papers are often cited and acclaimed by the scientific press. She played a lead part in the studies which led to the development of VivaStem Technology.

Sethupathi Periannan, MD
VP, Research
Dr. Sethupathi is a surgeon and has been in medical research for more than 20 years. He has performed surgeries in people and small as well as large animals. During his academic career he has published several papers in peer-reviewed medical and scientific journals including the key papers which led to the VivaStem Technology.

Advisors

Karl M. Nobert
FDA Consultant
Squire Sanders (U.S.) LLP, USA
Mr. Nobert’s legal practice focuses on the U.S. FDA’s regulation of prescription and over-the-counter drug products, biologics including cellular and tissue products; medical devices and veterinary products. He has considerable experience working with clients on the design and adoption of FDA regulatory strategies covering the manufacturing, marketing and sale of both human and veterinary regenerative products.

Kenneth P. Spina
Legal Counsel
Leydig, Voit and Mayer, Ltd.
Mr. Spina practices law in the field of intellectual property and is active in all areas of patent law, including legal opinions and counseling, due diligence, prosecution, litigation and licensing, with concentration in the pharmaceutical fields. Recent technologies with which he has been involved include organic synthesis, new molecules, pharmaceutical compositions, therapeutic indications, cosmetics and inorganic compositions.

David Wong, DVM, MS
Veterinary Consultant
Associate Professor & Section Head, Equine Medicine, Iowa State University
Dr. David Wong is an Associate Professor in the College of Veterinary Medicine at Iowa State University. He is also section head of the equine medicine division there. Dr. Wong’s training and research has made him an expert in equine emergency care. He is of a rare breed of professors that is a diplomate in two separate specialties: the American College of Veterinary Internal Medicine as well as the American College of Veterinary Emergency and Critical Care.